Last reviewed · How we verify

NCT04985838: HEADS:UP

Helping Ease Anxiety and Depression Following Stroke Stage 3

Completed NA Last updated 28 March 2023
What this trial tests

NA trial testing HEADS: UP (Helping Ease Anxiety and Depression) in Stroke in 64 participants. Completed in 1 September 2022.

Timeline
28 June 2021
Primary endpoint
1 September 2022
1 September 2022

Quick facts

Lead sponsorGlasgow Caledonian University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment64
Start date28 June 2021
Primary completion1 September 2022
Estimated completion1 September 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Glasgow Caledonian University

Who can join

18 and older, any sex, with Stroke or Cerebrovascular Accident Due to Cerebral Artery Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A mixed methods randomised controlled pilot trial, conducted in miniature of future definitive trial, in which the investigators will test optimised intervention and study processes. The investigators will individually randomise stroke survivor participants in a 1:1 allocation to: HEADS: UP or Control.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke.
    Allida SM, Hsieh CF, Cox KL, Patel K, et al · · 2023 · cited 11× · PMID 37417452 · DOI 10.1002/14651858.cd003437.pub5
  2. Meditation for the primary and secondary prevention of cardiovascular disease.
    Rees K, Takeda A, Court R, Kudrna L, et al · · 2024 · cited 5× · PMID 38358047 · DOI 10.1002/14651858.cd013358.pub2
  3. The HEADS: UP Development Study: Working with Key Stakeholders to Adapt a Mindfulness-Based Stress Reduction Course for People with Anxiety and Depression after Stroke.
    Lawrence M, Davis B, De Amicis L, Booth J, et al · · 2023 · cited 5× · PMID 36766930 · DOI 10.3390/healthcare11030355
  4. ESOC 2023 Abstract Book
    · 2023

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Glasgow Caledonian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04985838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing